Anti-amyloid antibodies (lecanemab, donanemab) are monoclonal antibodies that bind and clear amyloid-beta, the protein that aggregates into plaques in Alzheimers disease, and they are the clearest disease-modifying drugs to reach the clinic
Available from: [6] [cited 2024 Oct 18]
Healthcare providers should discuss all the potential benefits and side effects with their patients and consider the patients full medical history before initiating treatment with a Myers cocktail IV
Berendsen, H
Serum Bioavailable, Rather Than Total, 25-hydroxyvitamin D Levels Are Associated With Hepatocellular Carcinoma Survival
The TRIM24-SMAD3 complex is further recruited to chromatin, which enhances SMAD3 activation and immune response-related cytokine expression, thereby promoting enhanced breast cancer stemness, MDSC (myeloid-derived suppressor cell) recruitment, and metastasis